Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134688) titled 'A Study on the Efficacy and Safety of Denosumab in Treating Bone Metastases from Cancer' on Oct. 19.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Hospital of Hebei Medical University
Condition:
Malignant tumor bone metastasis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-10
Target Sample Size: Denosumab group:80;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=348318
Disclaimer: Curated by HT Syndication....